| |
|
Form Serial Number: |
IS20260721E00189
|
| 1.
Date of relevant event: |
16/07/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02630 |
| 4.
Name of listed corporation: |
Vigonvita Life Sciences Co., Ltd. - B - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
166,897,800 |
| 7.
Name of substantial shareholder (English) as printed on HKID Card/Passport: |
| (Surname) |
Shen |
| (Other names) |
Jingshan |
|
|
|
| 10.
Name of substantial shareholder (Chinese): |
沈敬山 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 14.
Details of relevant event: |
| |
Brief description of relevant event |
Capacity in which shares were/are held |
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange |
Off Exchange |
| Before relevant event |
After relevant event |
Highest price (per share) |
Average price (per share) |
Average consideration (per share) |
Nature of consideration |
| Long position |
| 1013 | You first acquire a notifiable interest because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
84,733,588 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 15.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
| |
| 16.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 84,733,588 | 50.77 |
|
| |
| 17.
Capacity in which interests disclosed in Box 16 are held: |
| Capacity code | Number of shares |
| |
| 2202 | Interest of your spouse |
| |
|
| |
| 18.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
| |
| 19.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| Spouse | Jin Jie | |
|
| |
| 20.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling shareholder | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
| |
| 21.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 22.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
| |
| 23.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
| |
| 24.
Supplementary information: |
本公司於2026年7月15日完成轉換100,220,667股境內非上市股份為H股，經轉換H股於2026年7月16日於聯交所上市。其中，沈敬山博士所持有的82,461,110股境內非上市股份已轉換為H股，於轉換完成後沈敬山博士持有82,461,110股H股。此外，由於金潔女士所持有的2,272,478股境內非上市股份亦已轉換為H股，因此沈敬山博士被視為於金潔女士（沈敬山博士之配偶）之2,272,478股H股中擁有權益。
|
| 25.
Log/Serial Number of the previous form: |
|
| 26.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 1: |
21/07/2026
(dd/mm/yyyy)
|
| |